Cargando…
Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months: The TEMPO Randomized Clinical Trial
Background. Incomplete control of troublesome regurgitation and extraesophageal manifestations of chronic gastroesophageal reflux disease (GERD) is a known limitation of proton pump inhibitor (PPI) therapy. This multicenter randomized study compared the efficacy of transoral incisionless fundoplicat...
Autores principales: | Trad, Karim S., Barnes, William E., Simoni, Gilbert, Shughoury, Ahmad B., Mavrelis, Peter G., Raza, Mamoon, Heise, Jeffrey A., Turgeon, Daniel G., Fox, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361451/ https://www.ncbi.nlm.nih.gov/pubmed/24756976 http://dx.doi.org/10.1177/1553350614526788 |
Ejemplares similares
-
Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm
por: Trad, Karim S., et al.
Publicado: (2016) -
Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms
por: Trad, Karim S., et al.
Publicado: (2011) -
The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective
por: Trad, Karim S., et al.
Publicado: (2018) -
Transoral incisionless fundoplication: current status
por: Sami Trad, Karim
Publicado: (2016) -
Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study
por: Trad, Karim Sami, et al.
Publicado: (2014)